Filing Details
- Accession Number:
- 0001209191-21-058521
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-01 17:12:47
- Reporting Period:
- 2021-09-01
- Accepted Time:
- 2021-10-01 17:12:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-09-01 | 15 | $2.88 | 13,373 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-02 | 15 | $2.88 | 13,388 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-03 | 15 | $2.85 | 13,403 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-07 | 15 | $2.79 | 13,418 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-08 | 15 | $2.89 | 13,433 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-09 | 15 | $2.77 | 13,448 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-10 | 15 | $2.78 | 13,463 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-13 | 15 | $2.96 | 13,478 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-14 | 15 | $3.02 | 13,493 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-15 | 15 | $2.86 | 13,508 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-16 | 15 | $2.91 | 13,523 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-17 | 15 | $2.85 | 13,538 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-20 | 15 | $2.82 | 13,553 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-21 | 15 | $2.81 | 13,568 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-22 | 15 | $2.76 | 13,583 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-23 | 15 | $2.75 | 13,598 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-24 | 15 | $2.74 | 13,613 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-27 | 15 | $2.79 | 13,628 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-28 | 15 | $2.76 | 13,643 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-29 | 15 | $2.82 | 13,658 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-09-30 | 15 | $2.72 | 13,673 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.